Literature DB >> 29808370

The Gender-Biased Effects of Intranasal MPTP Administration on Anhedonic- and Depressive-Like Behaviors in C57BL/6 Mice: the Role of Neurotrophic Factors.

Marissa Giovanna Schamne1, Josiel Mileno Mack1, Morgana Moretti1,2, Filipe Carvalho Matheus1, Roger Walz3, Laurence Lanfumey4, Rui Daniel Prediger5.   

Abstract

Depression is a highly prevalent and debilitating non-motor symptom observed during the early stages of Parkinson's disease (PD). Although PD prevalence is higher in men, the depressive symptoms in PD are more common in women. Therefore, the aim of this study was to investigate the development of anhedonic- and depressive-like behaviors in male and female mice and the potential mechanisms related to depressive symptoms in an experimental model of PD. Young adult male and female C57BL/6 mice (3 months old) received a single intranasal (i.n.) administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and were submitted to a battery of behavioral tasks (sucrose consumption, splash test, tail suspension, forced swimming and open field tests) to assess their emotional and motor profiles. Considering the role of sexual hormones in emotional behaviors, the same protocol of i.n. MPTP administration and the splash, tail suspension, and open field tests were conducted in ovariectomized (OVX) and aged C57BL/6 female (20 months old) mice. We also investigated the immunocontent of neurotrophins (BDNF, GDNF, and VEGF) in the hippocampus and prefrontal cortex by western blot. I.n.  MPTP administration induced more pronounced anhedonic- and selective depressive-like behaviors in female adult mice, also observed in OVX and aged female mice, with the absence of motor impairments. Furthermore, MPTP induced a more pronounced depletion of neurotrophins in the prefrontal cortex and hippocampus in female than male mice. This study provides new evidence of increased susceptibility of female mice to anhedonic- and depressive-like behaviors following i.n. MPTP administration. The observed gender-related effects of MPTP on emotional parameters seem to be linked to increased depletion of neurotrophins (particularly BDNF and GDNF) in the hippocampus and prefrontal cortex of female mice.

Entities:  

Keywords:  BDNF; Depression; GDNF; Gender differences; Intranasal MPTP; Neurotrophins; Parkinson’s disease

Mesh:

Substances:

Year:  2018        PMID: 29808370     DOI: 10.1007/s12640-018-9912-4

Source DB:  PubMed          Journal:  Neurotox Res        ISSN: 1029-8428            Impact factor:   3.911


  71 in total

1.  Neonatal exposure to constant light prevents anhedonia-like behavior induced by constant light exposure in adulthood.

Authors:  Bruno J Martynhak; Diego Correia; Lívia H Morais; Paula Araujo; Monica L Andersen; Marcelo M S Lima; Fernando M Louzada; Roberto Andreatini
Journal:  Behav Brain Res       Date:  2011-03-21       Impact factor: 3.332

Review 2.  Intranasal administration of neurotoxicants in animals: support for the olfactory vector hypothesis of Parkinson's disease.

Authors:  Rui D S Prediger; Aderbal S Aguiar; Filipe C Matheus; Roger Walz; Layal Antoury; Rita Raisman-Vozari; Richard L Doty
Journal:  Neurotox Res       Date:  2011-10-15       Impact factor: 3.911

Review 3.  Signaling pathways underlying the rapid antidepressant actions of ketamine.

Authors:  Ronald S Duman; Nanxin Li; Rong-Jian Liu; Vanja Duric; George Aghajanian
Journal:  Neuropharmacology       Date:  2011-09-02       Impact factor: 5.250

4.  Biphasic effects of MPP+, a possible parkinsonism inducer, on dopamine content and tyrosine hydroxylase mRNA expression in PC12 cells.

Authors:  Y Itano; Y Kitamura; Y Nomura
Journal:  Neurochem Int       Date:  1995-02       Impact factor: 3.921

Review 5.  VEGF and depression: a comprehensive assessment of clinical data.

Authors:  Anne Clark-Raymond; Angelos Halaris
Journal:  J Psychiatr Res       Date:  2013-05-17       Impact factor: 4.791

Review 6.  GDNF delivery for Parkinson's disease.

Authors:  N K Patel; S S Gill
Journal:  Acta Neurochir Suppl       Date:  2007

7.  Occurrence risk and structure of depression in Parkinson disease with and without dementia: results from the GEPAD Study.

Authors:  Oliver Riedel; Isabella Heuser; Jens Klotsche; Richard Dodel; Hans-Ulrich Wittchen
Journal:  J Geriatr Psychiatry Neurol       Date:  2009-12-30       Impact factor: 2.680

8.  Vascular endothelial growth factor signaling is required for the behavioral actions of antidepressant treatment: pharmacological and cellular characterization.

Authors:  Joshua Greene; Mounira Banasr; Boyoung Lee; Jennifer Warner-Schmidt; Ronald S Duman
Journal:  Neuropsychopharmacology       Date:  2009-06-24       Impact factor: 7.853

9.  Integrated molecular landscape of Parkinson's disease.

Authors:  J E Visser; G Poelmans; C J H M Klemann; G J M Martens; M Sharma; M B Martens; O Isacson; T Gasser
Journal:  NPJ Parkinsons Dis       Date:  2017-04-10

Review 10.  GDNF-based therapies, GDNF-producing interneurons, and trophic support of the dopaminergic nigrostriatal pathway. Implications for Parkinson's disease.

Authors:  Xavier d'Anglemont de Tassigny; Alberto Pascual; José López-Barneo
Journal:  Front Neuroanat       Date:  2015-02-13       Impact factor: 3.856

View more
  2 in total

Review 1.  Application of Neurotoxin-Induced Animal Models in the Study of Parkinson's Disease-Related Depression: Profile and Proposal.

Authors:  Ya-Kui Mou; Li-Na Guan; Xiao-Yan Yao; Jia-Hui Wang; Xiao-Yu Song; Yong-Qiang Ji; Chao Ren; Shi-Zhuang Wei
Journal:  Front Aging Neurosci       Date:  2022-05-13       Impact factor: 5.702

Review 2.  Exercise-Induced Neuroprotection and Recovery of Motor Function in Animal Models of Parkinson's Disease.

Authors:  Ewelina Palasz; Wiktor Niewiadomski; Anna Gasiorowska; Adrianna Wysocka; Anna Stepniewska; Grazyna Niewiadomska
Journal:  Front Neurol       Date:  2019-11-01       Impact factor: 4.003

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.